This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Ariad Pharmaceuticals(ARIA - Get Report) is upgraded to hold at TheStreet Ratings.
Agrium(AGU - Get Report) estimates and target were reduced at Goldman Sachs. Shares of AGU are now seen reaching $86. Estimates were also cut, given lower realized margins, Goldman said. Neutral rating.
Amphenol(APH - Get Report) was downgraded at Ticonderoga from Neutral to Sell. Valuation call, based on a $38 price target, Ticonderoga said.
Ann Taylor(ANN) numbers were increased at UBS. Shares are now seen reaching $33. Estimates were also increased on strong sales and margin gains at LOFT, e-commerce and outlets, UBS said. Buy rating.
Archer-Daniels(ADM - Get Report) was initiated with a Neutral rating at Ticonderoga. The company is trading at book value, but lacks near-term catalysts, Ticonderoga said.
Brocade's(BRCD - Get Report) target was raised at ThinkEquity. Shares are now seen reaching $6, according to ThinkEquity. Company is carrying a lot of momentum into 2012, ThinkEquity said. Buy rating.
CBOE Holdings(CBOE - Get Report) estimates were raised at Oppenheimer through 2012. Exceptional market volatility drove an exceptional quarter, Oppenheimer said. Maintain $29 price target and Outperform rating.
Church & Dwight(CHD - Get Report) numbers were increased at Jefferies. Estimates were raised through 2012. Company is positioned well for a slow-growth environment, Jefferies said. Hold rating and new $43 price target.
Church & Dwight estimates were lowered through 2012 at UBS. Some noise, but a generally in-line quarter, UBS said. Maintain $44 price target and Neutral rating.
Clean Harbors(CLH - Get Report) numbers were increased at Goldman Sachs. Estimates were raised through 2013. Company is seeing higher sales, Goldman said. Neutral rating and new $57 price target.
CME(CME - Get Report) target was boosted at Jefferies. Shares are now seen reaching $315. Core business trends are picking up, Jefferies said. Buy rating.
Comcast(CMCSA - Get Report) estimates, target were cut at Morgan Stanley. Shares are now seen reaching $27. Estimates were also reduced, given lower expected results at NBC Universal, Morgan Stanley said. Equal-weight rating.
Consolidated Edison(ED - Get Report) numbers were boosted at Goldman Sachs. Shares are now seen reaching $52. Estimates were also increased, given a better outlook for the company's nonregulated assets, Goldman said. Sell rating.
Con-Way(CNW) estimates were lowered at Sterne Agee through 2012. Pension and 401(k) headwinds, Sterne Agee said. Maintain Buy rating and $48 price target.